News Industry News Amgen and Cytokinetics Announce Positive Top-Line Results From COSMIC-HF, A Phase 2 Trial of Omecamtiv Mecarbil in Patients With Chronic Heart Failure October 27, 2015
News Daily News CABG Plus Stem Cells Equals Improved LV Function in MI Patients with Heart Failure Jason Kahn June 06, 2011
News Conference News STICH: CABG Does Not Extend Survival Over Medical Therapy in Heart Failure Patients Caitlin E. Cox April 04, 2011